Article Cited by others


Radioiodine therapy for castration-resistant prostate cancer following prostate-specific membrane antigen promoter-mediated transfer of the human sodium iodide symporter

Gao Xiao-Feng, Zhou Tie, Chen Guang-Hua, Xu Chuan-Liang, Ding Ye-Lei, Sun Ying-Hao

Year : 2014| Volume: 16| Issue : 1 | Page no: 120-123

   This article has been cited by
1 Targeting strategies of adenovirus-mediated gene therapy and virotherapy for prostate cancer
Zhonglin Cai,Haidi Lv,Wenjuan Cao,Chuan Zhou,Qiangzhao Liu,Hui Li,Fenghai Zhou
Molecular Medicine Reports. 2017; 16(5): 6443
[Pubmed]  [Google Scholar] [DOI]
2 The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease
James C Evans,Meenakshi Malhotra,John F Cryan,Caitriona M OĉDriscoll
British Journal of Pharmacology. 2016; 173(21): 3041
[Pubmed]  [Google Scholar] [DOI]
3 Glycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake
Taemoon Chung,Hyewon Youn,Chan Joo Yeom,Keon Wook Kang,June-Key Chung,Abhijit De
PLOS ONE. 2015; 10(11): e0142984
[Pubmed]  [Google Scholar] [DOI]
4 Theranostic Studies of Human Sodium Iodide Symporter Imaging and Therapy Using 188Re: A Human Glioma Study in Mice
Rui Guo,M. Zhang,Yun Xi,Yufei Ma,Sheng Liang,Shuo Shi,Ying Miao,Biao Li,Gabriele Multhoff
PLoS ONE. 2014; 9(7): e102011
[Pubmed]  [Google Scholar] [DOI]


Read this article